ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

John Durant “Going Home” To Birmingham

February 5, 1988

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

National Cancer Act: Early Promises Were Overstated

May 15, 1998

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

Feinstein Reintroduces New National Cancer Act

June 13, 2003